Literature DB >> 8372733

Mechanisms of NSAIDs on joint destruction in osteoarthritis.

K D Rainsford1.   

Abstract

To determine the effects of NSAIDs on cartilage and bone in osteoarthritis we have examined (a) the rates of drug uptake into cartilage; (b) the effects in vitro of the drugs on the synthesis and degradation of cartilage proteoglycans (PrGns), synovial production of interleukins (IL) 1, 6 and 8, and prostanoids; and (c) cartilage proteoglycan and synovial eicosanoid (Eics) concentrations, as well as bone histopathology and histomorphometry in subjects with primary osteoarthritis (OA) of the hip who received NSAIDs for approximately one year or longer prior to arthroplasty. While the latter study is still in progress results to date show that (a) the drug uptake may be a determinant of its actions, and (b) NSAIDs vary considerably in their effects on synovial production of IL's and Eics as well as cartilage PrGns. The summative effects of these parameters may influence the outcome of NSAIDs on cartilage and bone integrity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8372733

Source DB:  PubMed          Journal:  Agents Actions Suppl        ISSN: 0379-0363


  3 in total

Review 1.  Current pharmacological treatment of osteoarthritis.

Authors:  F A Wollheim
Journal:  Drugs       Date:  1996       Impact factor: 9.546

2.  Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis.

Authors:  E Gineyts; J A Mo; A Ko; D B Henriksen; S P Curtis; B J Gertz; P Garnero; P D Delmas
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

3.  Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac.

Authors:  M A Alvarez-Soria; R Largo; J Santillana; O Sánchez-Pernaute; E Calvo; M Hernández; J Egido; G Herrero-Beaumont
Journal:  Ann Rheum Dis       Date:  2006-02-13       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.